Citigroup and Mizuho are acting as joint book-running managers and underwriters for the proposed Offering. In addition, Diversified intends to grant the underwriters an option to purchase up to an ...
JPMorgan Diversified Return U.S. Small Cap Equity ETF Trading Up 0.5 % Shares of JPSE opened at $47.25 on Wednesday. The firm has a fifty day simple moving average of $47.52 and a two-hundred day ...
BIRMINGHAM, Ala., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Diversified Energy Company PLC (LSE: DEC; NYSE: DEC) (“Diversified” or the "Company"), an independent energy company focused on natural gas ...
Gannett Co., Inc. (NYSE: GCI) has entered into an asset purchase agreement with Hearst, a leading global diversified information services and media company, to divest the Austin American ...
DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services ...
The Fund is non-diversified and can invest a greater portion ... We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view.
President Donald Trump’s administration moved Wednesday to revoke federal approval of New York City’s nascent congestion pricing toll model, prompting New York’s Metropolitan Transportation ...
President Donald Trump's administration has moved to block the New York City congestion pricing toll program. U.S. Transportation Secretary Sean Duffy penned a letter informing New York Gov. Kathy ...
President Trump’s administration signed the death warrant for New York’s congestion pricing scheme Wednesday — a move widely cheered as a win for the working class. In a letter to Gov.
NEW YORK — President Trump’s administration on Wednesday ordered a halt to congestion pricing tolls in New York City, which thin traffic and fund mass transit by making people pay to drive ...
After decades of a diversified healthcare business model, Johnson & Johnson has announced it plans to split off its consumer health division from its pharma and medical device operations.